| Citation: |
LIU Yiran, LI Yingnan, SUN Yan, ZHANG Li. Value of serological indicators in predicting early neurological deterioration in patients with acute ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2024, 28(13): 63-66, 71. DOI: 10.7619/jcmp.20241162
|
To explore the value of serological indicators in predicting early neurological deterioration (END) in patients with acute ischemic stroke (AIS).
A total of 276 AIS patients were selected as the study subjects and divided into END group (72 cases) and non-END group (204 cases) based on the occurrence of END. Clinical data from all AIS patients were collected. Multivariable Logistic regression analysis was used to analyze the independent influencing factors of END in AIS patients. The receiver operating characteristic (ROC) curve was used to evaluate the predictive value of various serological markers for END.
Univariate analysis showed that the END group had a significantly higher proportion of patients aged >75 years, higher National Institutes of Health Stroke Scale (NIHSS) scores, fasting blood glucose (FBG), uric acid, fibrinogen, platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) compared to the non-END group (P < 0.05). Multivariable Logistic regression analysis revealed that age (OR=1.322, 95%CI, 1.049 to 1.666), NIHSS score (OR=1.793, 95%CI, 1.281 to 2.510), FBG (OR=1.392, 95%CI, 1.126 to 1.722), PLR (OR=1.505, 95%CI, 1.128 to 2.008) and NLR (OR=1.677, 95%CI, 1.280 to 2.197) were independent influencing factors for END in AIS patients. The ROC curve showed that the areas under the curve (AUC) for FBG, PLR and NLR in predicting END in AIS patients were 0.642, 0.581 and 0.759, respectively.
PLR, NLR and FBG are independent influencing factors for the occurrence of END in AIS patients. NLR has a higher predictive value for END in AIS patients.
| [1] |
MENDELSON S J, PRABHAKARAN S. Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review[J]. JAMA, 2021, 325(11): 1088-1098. doi: 10.1001/jama.2020.26867
|
| [2] |
RABINSTEIN A A. Update on treatment of acute ischemic stroke[J]. Continuum, 2020, 26(2): 268-286.
|
| [3] |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48(4): 246-257.
|
| [4] |
VYNCKIER J, MAAMARI B, GRUNDER L, et al. Early neurologic deterioration in lacunar stroke: clinical and imaging predictors and association with long-term outcome[J]. Neurology, 2021, 97(14): e1437-e1446.
|
| [5] |
ANTOS A, CZŁONKOWSKA A, SMOLINSKI L, et al. Early neurological deterioration in Wilson's disease: a systematic literature review and meta-analysis[J]. Neurol Sci, 2023, 44(10): 3443-3455. doi: 10.1007/s10072-023-06895-6
|
| [6] |
SHARMA A, PANDIT A K, MISHRA B, et al. Early neurological deterioration in acute ischemic stroke[J]. Ir J Med Sci, 2024, 193(2): 949-955. doi: 10.1007/s11845-023-03485-5
|
| [7] |
NAIR S B, SOMARAJAN D, PILLAI R K, et al. Predictors of early neurological deterioration following intravenous thrombolysis: difference between risk factors for ischemic and hemorrhagic worsening[J]. Ann Indian Acad Neurol, 2022, 25(4): 627-633. doi: 10.4103/aian.aian_893_21
|
| [8] |
KANAMARU T, SUDA S, MURAGA K, et al. Albuminuria predicts early neurological deterioration in patients with acute ischemic stroke[J]. J Neurol Sci, 2017, 372: 417-420. doi: 10.1016/j.jns.2016.11.007
|
| [9] |
SHARMA D, BHASKAR S M M. Prognostic role of the platelet-lymphocyte ratio in acute ischemic stroke patients undergoing reperfusion therapy: a meta-analysis[J]. J Cent Nerv Syst Dis, 2022, 14: 11795735221110373.
|
| [10] |
GONG P Y, LIU Y K, GONG Y C, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke[J]. J Neuroinflammation, 2021, 18(1): 51. doi: 10.1186/s12974-021-02090-6
|
| [11] |
TIAN T, WANG L J, XU J L, et al. Prediction of early neurological deterioration in acute ischemic stroke patients treated with intravenous thrombolysis[J]. J Cereb Blood Flow Metab, 2023, 43(12): 2049-2059. doi: 10.1177/0271678X231200117
|
| [12] |
LATTANZI S, NORATA D, BROGGI S, et al. Neutrophil-to-lymphocyte ratio predicts early neurological deterioration after endovascular treatment in patients with ischemic stroke[J]. Life, 2022, 12(9): 1415. doi: 10.3390/life12091415
|
| [13] |
SAREJLOO S, KHERADJOO H, HAGHI S E, et al. Neutrophil-to-lymphocyte ratio and early neurological deterioration in stroke patients: a systematic review and meta-analysis[J]. Biomed Res Int, 2022, 2022: 8656864.
|
| [14] |
魏丽, 邢婷婷, 陆练军, 等. 急性缺血性脑卒中患者阿替普酶静脉溶栓后发生早期神经功能恶化的危险因素分析[J]. 中国临床神经科学, 2023, 31(3): 287-292. https://www.cnki.com.cn/Article/CJFDTOTAL-LCSK202303006.htm
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: